Merus NV is a clinical-stage oncology company developing innovative bispecific antibody therapeutics to treat cancer. The company focuses on creating therapies for solid and hematologic tumors.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!